secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2024-12-17T23:59:59+00:00
Accession:  0001213900-24-109825
Event type: debt
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Oramed recieves $13.2M from Scilex, slashing Tranche A principal to $7.7M
-------------------------------------------------------------------------

- Scilex paid ~$13.2M on Dec 13, 2024, satisfying the $15M installment due Dec 21.
- Combined with prior payments, $94.2M of original $101.9M Tranche A Note has been repaid or refinanced.
- Remaining Scilex debt to Oramed: $7.675M (Tranche A) and $25M (Tranche B Notes).
- Payment stems from September 2023 securities purchase agreement and subsequent October 2024 refinancing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390024109825/0001213900-24-109825-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390024109825/ea0225149-8k_oramed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-109825

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer